Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Insulin Resistance in MAFLD
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4156-4156
Open Access | Times Cited: 282

Showing 1-25 of 282 citing articles:

Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 199
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15489-15489
Open Access | Times Cited: 187
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Xiaodong Zhou, Jingjing Cai, Giovanni Targher, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
Hiroshi Kitamura
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3219-3219
Open Access | Times Cited: 56
Management of diabesity: Current concepts
Maria Michaelidou, Joseph M. Pappachan, Mohammad Sadiq Jeeyavudeen
World Journal of Diabetes (2023) Vol. 14, Iss. 4, pp. 396-411
Open Access | Times Cited: 50
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2844-2844
Open Access | Times Cited: 47
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
Tao Bo, Ling Gao, Zhenyu Yao, et al.
Cell Metabolism (2024) Vol. 36, Iss. 5, pp. 947-968
Closed Access | Times Cited: 27
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease
Qingling Chen, Pingping Hu, Xiaoxue Hou, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 5
Novel bioactive peptides alleviate Western diet-induced MAFLD in C57BL/6J mice by inhibiting NLRP3 inflammasome activation and pyroptosis via TLR4/NF-κB and Keap1/Nrf2/HO-1 signaling pathways
Vipul Wayal, Shulhn-Der Wang, Chang‐Chi Hsieh
International Immunopharmacology (2025) Vol. 148, pp. 114177-114177
Open Access | Times Cited: 4
High-Intensity Interval Training Reduces Liver Enzyme Levels and Improves MASLD-Related Biomarkers in Overweight/Obese Girls
Wissal Abassi, Nejmeddine Ouerghi, M. Hammami, et al.
Nutrients (2025) Vol. 17, Iss. 1, pp. 164-164
Open Access | Times Cited: 2
Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
Pervej Alom Barbhuiya, Ameena Ahmed, Partha Dutta, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access | Times Cited: 2
Ferroptosis and metabolic dysfunction‐associated fatty liver disease: Is there a link?
Gong Feng, Christopher D. Byrne, Giovanni Targher, et al.
Liver International (2022) Vol. 42, Iss. 7, pp. 1496-1502
Open Access | Times Cited: 59
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3649-3649
Open Access | Times Cited: 48
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 594-594
Open Access | Times Cited: 28
Intestinal permeability and its significance in psychiatric disorders – A narrative review and future perspectives
Jakub Wasiak, Oliwia Gawlik-Kotelnicka
Behavioural Brain Research (2023) Vol. 448, pp. 114459-114459
Closed Access | Times Cited: 28
Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota
Feiwei Cao, Qinchao Ding, Hui Zhuge, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 24
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Anna Gudan, Katarzyna Kozłowska‐Petriczko, Ewa Wunsch, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1323-1323
Open Access | Times Cited: 23
Adipose-derived extracellular vesicles – a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
Dušan Mladenović, Milena Vesković, Nikola Šutulović, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 18-34
Closed Access | Times Cited: 14
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Haixiang Zheng, Leonardo A. Sechi, Eliano Pio Navarese, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 61-61
Open Access | Times Cited: 12
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 12
Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity
María Ángeles Núñez‐Sánchez, María Antonia Martínez‐Sánchez, José Ignacio Martínez‐Montoro, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 7, pp. 1781-1792
Open Access | Times Cited: 10
Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis
Kazuo Kajita, Isao Ishii, Ichiro Mori, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 932-932
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top